Clinical Trial Update: Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of convalescent plasma in patients with severe COVID-19 disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Disease

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Hospital Central Militar | Conditions: Severe COVID-19 Disease | Phase 2 | Status: COMPLETED